Overview and critical revision of clinical assessment tools in chemotherapy‐induced peripheral neurotoxicity

SB Park, P Alberti, NA Kolb… - Journal of the …, 2019 - Wiley Online Library
Chemotherapy‐induced peripheral neurotoxicity (CIPN) is a major toxicity of cancer
treatment, leading to dose reduction and premature treatment cessation, potentially affecting …

Assessing chemotherapy-induced peripheral neuropathy with patient reported outcome measures: a systematic review of measurement properties and considerations …

T Li, SB Park, E Battaglini, MT King, MC Kiernan… - Quality of Life …, 2022 - Springer
Purpose Chemotherapy-induced peripheral neuropathy (CIPN) is a common toxicity of
cancer treatment, with potential to significantly impact cancer survivors' long-term quality of …

Psychometric testing of the functional assessment of cancer therapy/gynecologic oncology group—neurotoxicity (FACT/GOG-Ntx) subscale in a longitudinal study of …

HL Cheng, V Lopez, SC Lam, AKT Leung, YC Li… - Health and quality of life …, 2020 - Springer
Background The aim of this study was to evaluate the psychometric properties of the
Functional Assessment of Cancer Therapy/Gynecologic Oncology Group—Neurotoxicity …

Patient-reported outcome measures in chemotherapy-induced peripheral neurotoxicity: defining minimal and clinically important changes

T Li, HC Timmins, T Trinh, D Mizrahi, M Harrison… - Journal of the National …, 2023 - jnccn.org
Background: Chemotherapy-induced peripheral neurotoxicity (CIPN) is a common
complication of cancer treatment that produces functional disability. Increasingly, patient …

Evaluating the safety, feasibility, and efficacy of non-invasive neuromodulation techniques in chemotherapy-induced peripheral neuropathy: A systematic review

M Wang, Y Yin, H Yang, Z Pei, A Molassiotis - European Journal of …, 2022 - Elsevier
Purpose This systematic review was conducted to evaluate the best available evidence
regarding the use of non-invasive neuromodulation techniques for managing chemotherapy …

Redefining chemotherapy-induced peripheral neuropathy through symptom cluster analysis and patient-reported outcome data over time

M Wang, HL Cheng, V Lopez, R Sundar, J Yorke… - BMC cancer, 2019 - Springer
Background Chemotherapy-induced peripheral neuropathy (CIPN) is common among
cancer patients treated with neurotoxic chemotherapy agents. Better knowledge on symptom …

Obtaining SF-6D utilities from FACT-H&N in thyroid carcinoma patients: development and results from a mapping study

Q Yang, D Huang, L Jiang, Y Tang… - Frontiers in …, 2023 - frontiersin.org
Objective There is limited evidence for mapping clinical tools to preference-based generic
tools in the Chinese thyroid cancer patient population. The current study aims to map the …

Clinical and biochemical markers in CIPN: A reappraisal

R Bonomo, G Cavaletti - Revue Neurologique, 2021 - Elsevier
The increased survival of cancer patients has raised growing public health concern on
associated long-term consequences of antineoplastic treatment. Chemotherapy-induced …

[HTML][HTML] Risk factors of paclitaxel-induced peripheral neuropathy in patients with breast cancer: a prospective cohort study

S Lixian, Y Xiaoqian, G Luyan, Z Lizhi, D Rui… - Frontiers in …, 2024 - frontiersin.org
Objective Chemotherapy-induced peripheral neuropathy (CIPN) is a common and severe
adverse reaction in taxane-based chemotherapy. This study aimed to analyze the risk …

Toxic neuropathies: chemotherapy induced peripheral neurotoxicity

P Alberti, G Cavaletti, DR Cornblath - Current opinion in …, 2019 - journals.lww.com
Toxic neuropathies: Chemotherapy Induced Peripheral Neurotox... : Current Opinion in
Neurology Toxic neuropathies: Chemotherapy Induced Peripheral Neurotoxicity : Current …